CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,105 enrolled
Drug / intervention
Ezetimibedrug
Likely dose
Ezetimibe 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00704535
NCT00704535N/ACompleted
CompareCT.gov

Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Ezetimibe Among Filipino Patients

Organon and Co·observational·Posted Jun 25, 2008·Updated Feb 9, 2022

In Brief

An observational study evaluating Ezetimibe for Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia. Completed, enrolled 4,105 participants.

Detailed Summary

The purpose of this study is to evaluate the overall safety, tolerability, and efficacy of Ezetimibe when used alone or in combination with a statin in patients with hypercholesterolemia

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Hypercholesterolemia, Homozygous Familial Hypercholesterolemia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 25, 2008
Enrollment StartMar 1, 2006
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 18.0 years ago

Interventions

Ezetimibedrug

1 tablet of 10 mg once daily